Aandelen in “Medische/verpleegkundige diensten”

Aandeel Datum Koers Evolutie
vlag Forte Biosciences Inc 26/08 76,990 USD
+0,03% 		+0,03%
vlag Fresenius Medical Care AG & Co. KGaA 2/11 22,610 USD
+0,62% 		+0,62%
vlag Fresenius Medical Care AG & Co. KGaA 3/11 39,040 EUR
-3,60% 		-3,60%
vlag Fulgent Genetics Inc 2/11 19,290 USD
-6,45% 		-6,45%

Nieuws over “Medische/verpleegkundige diensten”

2/11 · What's Next for The Ensign Group, Inc. Shareholders After 8.2% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline · Persbericht

2/11 · What's Next for The Ensign Group, Inc. Shareholders After 8.2% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline · Persbericht

29/10 · ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law · Persbericht

29/10 · DaVita Inc. 3rd Quarter 2026 Results · Persbericht

28/10 · Castle Biosciences to Participate in Upcoming Investor Conferences · Persbericht

27/10 · DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks · Persbericht

27/10 · ENSG Investor Class Action Filed: Ensign Group Investors Are Alerted to the Upcoming December 7 Deadline in the Securities Fraud Class Action to Recover Losses · Persbericht

26/10 · ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law · Persbericht

26/10 · ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law · Persbericht

22/10 · Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™ · Persbericht

21/10 · DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice · Persbericht

20/10 · Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders? · Persbericht

20/10 · Shareholders who lost money in shares of The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately · Persbericht

20/10 · What's Next for The Ensign Group, Inc. Shareholders After 8.2% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline · Persbericht

19/10 · DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call · Persbericht

19/10 · RAMSAY GENERALE DE SANTE : Availability of the 2026 URD - Evolution in the Governance - Annual General meeting on 4th December 2026 · Persbericht

19/10 · Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders? · Persbericht

15/10 · Shareholders who lost money in shares of acquired The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately · Persbericht

15/10 · Shareholders who lost money in shares of The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately · Persbericht

15/10 · DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care · Persbericht

15/10 · Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026 · Persbericht

Mijn selecties